School of Medicine
Showing 1-9 of 9 Results
Dee W. West
Professor of Health Research and Policy, Emeritus
Current Research and Scholarly Interests- Cancer etiology (diet, familial, genetic), especially breast, prostate and colon cancer
- Cancer surveillance (Cancer registration, cancer patterns)
- Cancer outcomes (Survival, quality of life, quality of care)
Postdoctoral Scholar, Health Policy
BioI am a Postdoctoral Scholar in Primary Care and Outcomes Research. I previously completed a PhD in Management Science and Engineering, MS in Bioengineering, and BS in Chemical Engineering at Stanford. In my postdoc, I am developing and applying data-driven methods and models to inform complex health policy decisions surrounding infectious diseases.
Alice S Whittemore
Professor of Health Research and Policy (Epidemiology) and of Biomedical Data Science, Emerita
Professor Emerita, Epidemiology and Population Health
Current Research and Scholarly InterestsCancers of the prostate, breast and ovary account for a major proportion of new cancer cases and cancer deaths in the U.S. each year. Our recent research focus has been on developing improved statistical methods for the design and conduct of studies involving hereditary predisposition and modifiable lifestyle characteristics in the etiologies of site-specific cancers.
Ph.D. Student in Health Policy, admitted Autumn 2019
BioErik is a PhD student in the Department of Health Research and Policy at Stanford University. Since 2006, he has been serving in the United States Army as a commissioned medical services officer, working predominately within its own system for health in the areas of operations, finance, and analytics. His most recently completed assignment was as the Chief Financial Officer for the Fort Knox, KY Medical Activity. His research interests reside in applying economic evaluations, simulations, and modeling to examine the costs and outcomes to the practices, policies, and overall design in health care affecting Maternal and Child Health.
Postdoctoral Scholar, Health Policy
BioBritni Wilcher, PhD, is a Postdoctoral Fellow in Health Services Research & Development. Dr. Wilcher earned her PhD in economics from American University in 2022. She is an applied microeconomist with interests in health, labor, and gender economics. Dr. Wilcher’s research focuses on the economics of health decision making and its implications for labor markets using quasi-experimental designs to draw causal inferences for historically disadvantaged populations. While completing her doctoral studies, Dr. Wilcher also conducted impact analysis of US regulations for think tanks and government agencies.
Prior to her doctoral studies, Dr. Wilcher completed a BA in Economics at Spelman College and MSc in International Health Care Management, Economics, and Policy at SDA Bocconi School of Management in Milan, Italy. During her masters, she specialized in the economics evaluation of pharmaceutical and medical devices. Dr. Wilcher applied that training as a senior consultant at Booz Allen Hamilton in Washington, DC and research fellow at the University of Exeter in England. Her work at Exeter, supporting an EU commission aimed at advancing the existing methodological framework for health technology assessment (HTA) of medical devices (MedtecHTA), was published in Value in Health, Health Economics, and the International Journal of Technology Assessment in Health Care.
Professor of Epidemiology and Population Health, of Biomedical Data Science and, by courtesy, of Genetics
BioDr. Witte joined the Stanford community in July 2021. In addition to serving as Vice Chair and professor in the Department of Epidemiology & Population Health, and as a professor of Biomedical Data Science and, by courtesy, of Genetics, he will also serve as a member of the Stanford Cancer Institute.
Dr. Witte is an internationally recognized expert in genetic epidemiology. His scholarly contributions include deciphering the genetic and environmental basis of prostate cancer and developing widely used methods for the genetic epidemiologic study of disease. His prostate cancer work has used comprehensive genome-wide studies of germline genetics, transcriptomics, and somatic genomics to successfully detect novel variants underlying the risk and aggressiveness of this common disease. A key aspect of this work has been distinguishing genetic factors that may drive increased prostate cancer risk and mortality among African American men. Providing an avenue to determine which men are more likely to be diagnosed with clinically relevant prostate cancer and require additional screening or specific treatment can help reduce disparities in disease prevalence and outcomes across populations. Dr. Witte has also developed novel hierarchical and polygenic risk score modeling for undertaking genetic epidemiology studies. These advances significantly improve our ability to detect disease-causing genes and to translate genetic epidemiologic findings into medical practice.
Dr. Witte has received the Leadership Award from the International Genetic Epidemiology Society (highest award), and the Stephen B. Hulley Award for Excellence in Teaching. His extensive teaching portfolio includes a series of courses in genetic and molecular epidemiology. He has mentored over 50 graduate students and postdoctoral fellows, serves on the executive committees of multiple graduate programs, and has directed a National Institutes of Health funded post-doctoral training program in genetic epidemiology for over 20 years. Recently appointed to the National Cancer Institute Board of Scientific Counselors, Dr. Witte has been continuously supported by the National Institutes of Health.